drugset / Trial / NCT00425997

Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension

NCT00425997 ↗

Phase 4 Completed 480 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the efficacy of valsartan/hydrochlorothiazide versus amlodipine and hydrochlorothiazide in patients with Stage 2 hypertension using 24-hr ambulatory blood pressure monitoring (ABPM)

Timeline

Start
2006-12
Primary completion
2007-10
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 10 mg —
Subject Hydrochlorothiazide Unknown 25 mg —
Subject Valsartan Unknown 320 mg —

Indications